HIV- 1- varianter med nedsat følsomhed over for maraviroc er udvalgt in vitro efter seriepassage af to CCR5- tropisme virus (0 laboratoriestammer, 2 kliniske isolater).
HIV-1 variants with reduced susceptibility to maraviroc have been selected in vitro, following serial passage of two CCR5-tropic viruses (0 laboratory strains, 2 clinical isolates).